Marieluise Kirchner

19PUBLICATIONS
165CO-AUTHORS
Haematological tumoursPacific Peoples land and water managementCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Dec 18, 2025
The Histone Modifier KANSL2 Is an Actionable Biomarker in Multiple Myeloma.

Kaiting Jiang, Marieluise Kirchner, Frederik Herzberg

|Nov 26, 2025
The Histone Modifier KANSL2 Is an Actionable Biomarker in Multiple Myeloma.

Kaiting Jiang, Marieluise Kirchner, Frederik Herzberg

|Nov 19, 2024
Proteomic insights into circadian transcription regulation: novel E-box interactors revealed by proximity labeling.

Manon Torres, Marieluise Kirchner, Caroline G Marks

Pageof 4